focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.50
Ask: 4.50
Change: 0.29 (8.26%)
Spread: 1.00 (28.571%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Tinci, Nasstar, 600 Group...

Tue, 30th Nov 2010 13:34

Environmental engineering group Tinci Holdings jumped after it announced contracts worth 45.4m Chinese Renminbi (£4.34m) to provide paper desulfurisation technology to two subsidiaries of the Dongguan Jiulong Paper Group. These projects are expected to start shortly and last for about six months.Nasstar, a provider of 'cloud' computer technology, reduced losses in the six months to September 30 as sales picked up. Pre-tax losses fell to £0.3m from £0.94m the previous year as sales climbed to £2.4m from £2m.The company is pinning its hopes on more workplaces adopting its technology to allow staff to work away from their desks. 'Patience is a difficult but important quality to maintain when you are early to market with a product that has large potential but which takes time for mainstream acceptance to catch up with the early adopters,' the company said.Engineering company 600 Group moved into profit in the six months to 2 October as it continued to recover from the downturn. Pre-tax profits totalled £1.5m, against a loss of £5.8m over the same period the previous year.Shares in Associated British Engineering surged after it moved into profit on the back of a jump in orders in its only subsidiary, the diesel engine maintenance specialist and spare parts supplier British Polar Engines, over summer. Pre-tax profits totalled £341,000, against a loss of £43,000 the previous year on revenues that climbed to £2.15m from £1.41m. 'The board continues to keep central costs at a low level and also continues in its quest to identify a suitable corporate transaction to take the group forward,' the company said.Carbon trader Trading Emissions has received an unsolicited approach to acquire its private equity portfolio. The board has now also initiated a formal sale process for the portfolio, to be managed by Liberum Capital, and will be soliciting for offers from interested parties.Software group First Derivatives has signed a joint venture with Trading Cross Connects US to produce a software and infrastructure solution for the high frequency trading community. Biomarker specialist Proteome Sciences says concluding licensing/commercial contracts may now occur later in the fourth quarter than expected and may not be fully reflected into revenues until 2011. In these circumstances it is unlikely that the profit before tax excluding non-exceptional items in 2010 will reach breakeven.Oncimmune Limited the lung cancer licensee is also removing Proteome Sciences annexin 1 autoantibody biomarker from its assay. Proteome does not anticipate that this will have a material effect on revenues in 2011.
More News
Today 12:23

IN BRIEF: Proteome Sciences promises AGM return to growth in 2024

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "confident and well positioned to see the business return to growth in 2024". The company swung to a loss in 2023, as revenue fell by 36% due to a delay in the timing of services contracts. Since the start of 2024, Proteome has seen "significant" customer engagement and interest in proteomics services, including a GBP500,000 contract for an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services, announced late last month.

Read more
Today 10:41

AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services.

Read more
26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's mass spectrometry services for the analysis of samples for an on-going clinical trial.

Read more
26 Apr 2024 09:14

LONDON MARKET OPEN: Thoma Bravo snaps up Darktrace for USD5 billion

(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.

Read more
10 Apr 2024 11:26

Proteome Sciences shares drop as revenue plunges and swings to loss

(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.

Read more
2 Jan 2024 14:44

Proteome launches San Diego lab operations

(Sharecast News) - Proteomics services provider Proteome Sciences announced the installation and start of operations at its new laboratory in San Diego, California, on Tuesday.

Read more
2 Jan 2024 10:52

IN BRIEF: Proteome Sciences says San Diego lab now fully operational

Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully operational. Back in May, Proteome had announced it was expanding its proteomics services to the US. Says that the lab is "well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes".

Read more
1 Dec 2023 12:01

Proteome Sciences issues profit warning after project delays

(Sharecast News) - Proteome Sciences, the AIM-listed protein sequencing contract research organisation, has warned it will swing to a net loss this year with full-year sales lower than expected.

Read more
30 Nov 2023 11:04

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
30 Nov 2023 09:42

Proteome Sciences shares drop as cuts annual revenue outlook

(Alliance News) - Proteome Sciences PLC shares plummeted on Thursday, after it cut its revenue outlook for 2023 amid delays to projects.

Read more
2 Oct 2023 10:17

Proteome Sciences sees shares surge on SysQuant service launch

(Alliance News) - Proteome Sciences PLC on Monday launched SysQuant SCP, a commercial service for single cell proteomics using isobaric labelling reagents.

Read more
25 Aug 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 pushes higher ahead of Fed chair speech

(Alliance News) - The FTSE 100 edged higher at midday on Friday as all eyes turned to US Federal Reserve Chair Jerome Powell's address at Jackson Hole later in the day.

Read more
25 Aug 2023 10:26

AIM WINNERS & LOSERS: Panthera Resources secures litigation financing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.